Prot# IRUSIRES0420/NU C05N2: Phase II Study of Skin Toxicity Dosing of IRESSA® (gefitinib) as Monotherapy in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

  • Patel, Jyoti D (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/27/064/30/14

Funding

  • University of Chicago (IRUSIRES0420/NU C05N2)
  • AstraZeneca Pharmaceuticals LP (IRUSIRES0420/NU C05N2)